Who could take the new weight-loss pill? In a nine-month trial on patients with type 2 diabetes, those on the highe ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

A new weight-loss pill taken daily could compete with injections like Ozempic, new research suggests. Patients, who all were ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.

A groundbreaking daily pill could compete with weight-loss injections such as Ozempic, research suggests. In trials, people ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...